Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methenamine Hippurate with Cranberry for UTI Prevention in Post-op Urinary Retention
NCT03818321Phase 2Completed
- Sponsor
- TriHealth
- Start
- Jun 2019
- Primary completion
- Jul 2021
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in urinary tract infection (UTI) comparing Methenamine Hippurate + Cranberry with Placebo + Cranberry (2 arms). Primary endpoint: Incidence of Urinary Tract Infection. Started Jun 2019; status: completed.
02
Drugs
methenamine hippurate
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03818321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03818321.